Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/86972
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Progestogens to prevent preterm birth in twin pregnancies: an individual participant data meta-analysis of randomized trials |
Author: | Schuit, E. Stock, S. Groenwold, R. Maurel, K. Combs, C. Garite, T. Spong, C. Thom, E. Rouse, D. Caritis, S. Saade, G. Zachary, J. Norman, J. Rode, L. Klein, K. Tabor, A. Cetingoz, E. Morrison, J. Magann, E. Briery, C. et al. |
Citation: | BMC Pregnancy and Childbirth, 2012; 12(1):1-6 |
Publisher: | BioMed Central |
Issue Date: | 2012 |
ISSN: | 1471-2393 1471-2393 |
Statement of Responsibility: | Ewoud Schuit ... Ben Willem J Mol ... et al. |
Abstract: | BACKGROUND Preterm birth is the principal factor contributing to adverse outcomes in multiple pregnancies. Randomized controlled trials of progestogens to prevent preterm birth in twin pregnancies have shown no clear benefits. However, individual studies have not had sufficient power to evaluate potential benefits in women at particular high risk of early delivery (for example, women with a previous preterm birth or short cervix) or to determine adverse effects for rare outcomes such as intrauterine death. METHODS/DESIGN We propose an individual participant data meta-analysis of high quality randomized, double-blind, placebo-controlled trials of progestogen treatment in women with a twin pregnancy. The primary outcome will be adverse perinatal outcome (a composite measure of perinatal mortality and significant neonatal morbidity). Missing data will be imputed within each original study, before data of the individual studies are pooled. The effects of 17-hydroxyprogesterone caproate or vaginal progesterone treatment in women with twin pregnancies will be estimated by means of a random effects log-binomial model. Analyses will be adjusted for variables used in stratified randomization as appropriate. Pre-specified subgroup analysis will be performed to explore the effect of progestogen treatment in high-risk groups. DISCUSSION Combining individual patient data from different randomized trials has potential to provide valuable, clinically useful information regarding the benefits and potential harms of progestogens in women with twin pregnancy overall and in relevant subgroups. |
Keywords: | Humans Pregnancy Complications Premature Birth Progestins Pregnancy Outcome Clinical Protocols Models, Statistical Pregnancy Adult Infant, Newborn Female Randomized Controlled Trials as Topic Pregnancy, Twin |
Rights: | © Schuit et al; licensee BioMed Central Ltd. 2012 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
DOI: | 10.1186/1471-2393-12-13 |
Published version: | http://dx.doi.org/10.1186/1471-2393-12-13 |
Appears in Collections: | Aurora harvest 7 Obstetrics and Gynaecology publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_86972.pdf | Published version | 296.93 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.